Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -34.382% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) O=C(NCc1ncc(C(F)(F)F)cc1Cl)Nc1ccccc1
b) O=C(Nc1ccc(F)c([N+](=O)[O-])c1)C1CC(=O)N(Cc2ccccc2)C1
Answer: b. O=C(Nc1ccc(F)c([N+](=O)[O-])c1)C1CC(=O)N(Cc2ccccc2)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(Nc1ccc(F)c([N+](=O)[O-])c1)C1CC(=O)N(Cc2ccccc2)C1
O=C(Nc1ccc(F)c([N+](=O)[O-])c1)C1CC(=O)N(Cc2ccccc2)C1
1-benzyl-N-(4-fluoro-3-nitrophenyl)-5-oxopyrrolidine-3-carboxamide